Rare mutations in non small cell lung cancer

Bookmark and Share
Published: 7 Aug 2018
Views: 1343
Rating:
Save
Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA

Dr Stinchcombe speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about rare mutations in non small cell lung cancer.

He focusses on RET mutations and rearrangements, with the latest drug details and targeted areas.

Dr Stinchcombe continues to discuss HER2 and MET.